Skip to main content
Inherited predispositions and hyperactive Ras in myeloid leukemogenesis.
Is liver metastasis in neuroblastoma an indication for treatment reduction?
ACTH deficiency in childhood cancer survivors.
Ewing sarcoma as a second malignant neoplasm after acute lymphoblastic leukemia.
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
Surviving childhood cancer; now what? Controversies regarding long-term follow-up.